Merck And Co
Merck & Co., Inc., commonly referred to as Merck, is a leading global healthcare company headquartered in the United States. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and biologic therapies. With a strong presence in North America, Europe, and Asia, the company is dedicated to improving health outcomes worldwide. Merck's core products include groundbreaking treatments in oncology, infectious diseases, and vaccines, notably the HPV vaccine Gardasil and the cancer immunotherapy Keytruda. These offerings are distinguished by their commitment to research and development, which has led to numerous key milestones in medical advancements. As a market leader, Merck consistently ranks among the top pharmaceutical companies globally, recognised for its contributions to public health and its robust pipeline of future therapies.
DitchCarbon Score
How does Merck And Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck And Co's score of 50 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merck And Co's reported carbon emissions
In 2023, Merck & Co., Inc., headquartered in the US, reported total greenhouse gas emissions of approximately 7,527,700,000 kg CO2e. This figure includes 718,400,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 184,200,000 kg CO2e from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The company also reported Scope 3 emissions of about 6,625,100,000 kg CO2e, which encompass all other indirect emissions that occur in the value chain. Merck has set ambitious climate commitments, aiming to reduce its absolute Scope 1 and Scope 2 greenhouse gas emissions by 46% by 2030, using 2019 as the base year. Additionally, the company targets a 30% reduction in absolute Scope 3 emissions within the same timeframe. These targets are aligned with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Merck's long-term commitment includes a net-zero target for all scopes by 2050, further demonstrating its dedication to sustainability and climate action. The company is actively working towards these goals through various initiatives aimed at reducing its carbon footprint and enhancing energy efficiency across its operations.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 869,200,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 586,300,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 5,586,300,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck And Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
